Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review

Australas J Dermatol. 2021 May;62(2):e347-e349. doi: 10.1111/ajd.13538. Epub 2021 Jan 23.

Authors

Adrian Diago¹, Luis Hueso², Mariano Ara-Martín³, Isabel Abadías-Granado¹

Affiliations

¹ Department of Dermatology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
² Department of Dermatology, Hospital de Manises, Valencia, Spain.
³ Department of Dermatology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

PMID: 33484581
DOI: 10.1111/ajd.13538

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Aged
Drug-Related Side Effects and Adverse Reactions / complications*
Drug-Related Side Effects and Adverse Reactions / physiopathology
Female
Humans
Immune Checkpoint Inhibitors / adverse effects*
Immune Checkpoint Inhibitors / therapeutic use
Lung Neoplasms / drug therapy
Lupus Erythematosus, Cutaneous / etiology*
Male
Nivolumab / adverse effects
Nivolumab / therapeutic use

Substances

Immune Checkpoint Inhibitors
Nivolumab